Drug recall · May 30, 2018
Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg recall
Why: Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.
- Lots / codes
Lot: GH70154, Exp 12/18
- Quantity
- 5256 bottles
- Company
- Exela Pharma Sciences LLC, Lenoir, NC
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 20, 2018 · Voluntary: Firm initiated
- Classified
- May 22, 2018
- Reported
- May 30, 2018
- Ended
- June 4, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diclofenac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.